Market By Source Type, Methodology, Applications, Products & Services, End-users And Geography | Forecast 2019-2027
Research has shown the intraoperative neuromonitoring market in the Asia-Pacific to fast progress at a CAGR of 7.97% in the forecast years of 2019-2027.
The countries reviewed in the Asia-Pacific intraoperative neuromonitoring market are:
• China
• Japan
• India
• South Korea
• ASEAN Countries
• Australia & New Zealand
• Rest of the Asia-Pacific
As one of the largest economies globally, China is renowned for its adoption of the latest technology and high-class infrastructure. It is the most heavily populated country in the world and boasts of the biggest consumer market. China has become one of the key medical device manufacturers in the world.
Report scope can be customized per your requirements. Request For Customization
The country’s 13th Five-Year Development Plan planned for the period of 2016-2020, is aimed at transforming its health services system. The health services system reform emphasizes the need for strengthening the three-tiered healthcare system. Meanwhile, the transformation of the health insurance system is also in progress. With the objective of increasing the affordability of the healthcare resources among the masses, the government plans to establish a consolidated system for health insurance by the year 2020.
Being one of the most technologically advanced countries in the world, Japan is equipped with innovative techniques for performing surgeries. The Japanese government has realized the significance of robots in various spheres, including healthcare. As the country plans to explore the domain of healthcare robotics, the upcoming years will see critical surgeries for neurology being performed with the help of robots. The country possesses the largest number of robotic machines in the world.
Compared with other Asian countries, the mortality rate in Japan is significantly lower, which can be attributed to the awareness of health issues, cessation of smoking, change in lifestyles and advanced public healthcare. The market for intraoperative neuromonitoring in Japan is expected to be driven by factors such as advancement in technology as well as the rise in the elderly population.
Nihon Kohden engages in the development, manufacture and distribution of medical electronic equipment such as equipment for physiological measurement, which involves electrocardiographs, stimulators and diagnostic information systems. The company launched an IONM system called Neuromaster MEE-2000A in February 2016, which is used in neurology, spine, vascular orthopedic and otolaryngologic procedures. Founded in 1951, Nihon Kohden is headquartered in Shinjuku-ku, Japan.
Market By Type, Application, E ..
VIEW REPORT
Market By Device Type, Therape ..
VIEW REPORT
Market By Type, Application, T ..
VIEW REPORT
Market By Technology, Applicat ..
VIEW REPORT
Market By Application, Type, E ..
VIEW REPORT
Market by Therapeutics, Diagno ..
VIEW REPORT
Market by Type, Application, E ..
VIEW REPORT1.
ASIA-PACIFIC
INTRAOPERATIVE NEUROMONITORING MARKET - SUMMARY
2.
INDUSTRY
OUTLOOK
2.1. MARKET DEFINITION
2.2. KEY INSIGHTS
2.2.1.
OUTSOURCED
INTRAOPERATIVE NEUROMONITORING IS EXPECTED TO DOMINATE THE MARKET
2.2.2.
EP IS A WIDELY
USED METHODOLOGY OF INTRAOPERATIVE NEUROMONITORING
2.2.3.
SPINAL SURGERY
IS THE LARGEST APPLICATION OF INTRAOPERATIVE NEUROMONITORING
2.2.4.
SERVICES
SEGMENT IS GROWING AT A RAPID RATE
2.2.5.
AMBULATORY
SURGICAL CENTERS (ASCs) ARE RAPIDLY ADOPTING INTRAOPERATIVE NEUROMONITORING
2.3. PORTER’S FIVE FORCE ANALYSIS
2.3.1.
THREAT OF NEW
ENTRANTS
2.3.2.
THREAT OF
SUBSTITUTE
2.3.3.
BARGAINING
POWER OF SUPPLIERS
2.3.4.
BARGAINING
POWER OF BUYERS
2.3.5.
INTENSITY OF
COMPETITIVE RIVALRY
2.4. MARKET ATTRACTIVENESS INDEX
2.5. VENDOR SCORECARD
2.6. MARKET DRIVERS
2.6.1.
INCREASING
NEUROLOGICAL AND OTHER DISORDERS LEADING TO SURGERIES
2.6.2.
TECHNOLOGICAL
ADVANCEMENT
2.6.3.
REDUCTION OF
COMPLICATION DURING COMPLEX SURGERIES USING INTRAOPERATIVE NEUROMONITORING
2.6.4.
INCREASING
AGING POPULATION
2.7. MARKET RESTRAINTS
2.7.1.
HIGH COST OF
IONM DEVICES AND SERVICES
2.7.2.
LACK OF
SKILLED OPERATORS
2.8. MARKET OPPORTUNITIES
2.8.1.
RISE IN DEMAND
FOR THE USE OF INTRAOPERATIVE NEUROMONITORING FOR MINIMALLY INVASIVE SURGERIES
2.8.2.
DEVELOPMENT OF
REMOTE INTRAOPERATIVE NEUROMONITORING
2.8.3.
EMERGENCE OF
PORTABLE INTRAOPERATIVE NEUROMONITORING
2.9. MARKET CHALLENGES
2.9.1.
AVAILABILITY
OF LESS COSTLY SUBSTITUTES
3.
INTRAOPERATIVE
NEUROMONITORING MARKET OUTLOOK - BY SOURCE TYPE
3.1. INSOURCED INTRAOPERATIVE NEUROMONITORING
3.2. OUTSOURCED INTRAOPERATIVE NEUROMONITORING
4.
INTRAOPERATIVE
NEUROMONITORING MARKET OUTLOOK - BY METHODOLOGY
4.1. EEG MONITORING
4.2. EMG MONITORING
4.3. EP MONITORING
4.3.1.
SEP MONITORING
4.3.2.
TCMEP
MONITORING
4.3.3.
BAEP
MONITORING
4.3.4.
VEP MONITORING
5.
INTRAOPERATIVE
NEUROMONITORING MARKET OUTLOOK - BY APPLICATIONS
5.1. SPINAL SURGERY
5.2. ENT SURGERY
5.3. NEUROSURGERY
5.4. VASCULAR SURGERY
5.5. ORTHOPEDIC SURGERY
5.6. OTHER SURGERIES
6.
INTRAOPERATIVE
NEUROMONITORING MARKET OUTLOOK - BY PRODUCTS & SERVICES
6.1. SYSTEMS
6.2. ACCESSORIES
6.3. SERVICES
7.
INTRAOPERATIVE
NEUROMONITORING MARKET OUTLOOK - BY END-USERS
7.1. HOSPITALS
7.2. AMBULATORY SURGICAL CENTERS (ASCs)
8.
INTRAOPERATIVE
NEUROMONITORING MARKET - ASIA-PACIFIC
8.1. CHINA
8.2. JAPAN
8.3. INDIA
8.4. SOUTH KOREA
8.5. ASEAN COUNTRIES
8.6. AUSTRALIA & NEW ZEALAND
8.7. REST OF ASIA-PACIFIC
9.
COMPETITIVE
LANDSCAPE
9.1. ACCURATE NEUROMONITORING
9.2. INOMED MEDIZINTECHNIK GMBH
9.3. CADWELL
9.4. MOBERG RESEARCH, INC. (DAYONE MEDICAL LLC)
9.5. CNS NEUROMONITORING
9.6. COMPUTATIONAL DIAGNOSTICS
9.7. EMOTIV
9.8. INTRANERVE
9.9. MEDSURANT MONITORING
9.10.
MEDTRONIC
9.11.
NATUS MEDICAL
9.12.
SPECIALTYCARE
9.13.
NEUROMONITORING
TECHNOLOGIES
9.14.
NEUROSENTINEL
9.15.
NIHON KOHDEN
9.16.
NUVASIVE
9.17.
CHECKPOINT
SURGICAL
9.18.
ZYNEX
9.19.
ORIMTEC
10. RESEARCH METHODOLOGY & SCOPE
10.1.
RESEARCH SCOPE
& DELIVERABLES
10.1.1.
OBJECTIVES OF
STUDY
10.1.2.
SCOPE OF STUDY
10.2.
SOURCES OF
DATA
10.2.1.
PRIMARY DATA
SOURCES
10.2.2.
SECONDARY DATA
SOURCES
10.3.
RESEARCH
METHODOLOGY
10.3.1.
EVALUATION OF
PROPOSED MARKET
10.3.2.
IDENTIFICATION
OF DATA SOURCES
10.3.3.
ASSESSMENT OF
MARKET DETERMINANTS
10.3.4.
DATA
COLLECTION
10.3.5.
DATA
VALIDATION & ANALYSIS
TABLE 1: ASIA-PACIFIC INTRAOPERATIVE NEUROMONITORING MARKET, BY COUNTRY,
2019-2027 (IN $ MILLION)
TABLE 2: VENDOR SCORECARD
TABLE 3: ASIA-PACIFIC INTRAOPERATIVE NEUROMONITORING MARKET, BY SOURCE
TYPE, 2019-2027 (IN $ MILLION)
TABLE 4: ASIA-PACIFIC INTRAOPERATIVE NEUROMONITORING MARKET, BY
METHODOLOGY, 2019-2027 (IN $ MILLION)
TABLE 5: ASIA-PACIFIC INTRAOPERATIVE NEUROMONITORING MARKET, BY
APPLICATIONS, 2019-2027 (IN $ MILLION)
TABLE 6: ASIA-PACIFIC INTRAOPERATIVE NEUROMONITORING MARKET, BY PRODUCTS
& SERVICES, 2019-2027 (IN $ MILLION)
TABLE 7: ASIA-PACIFIC INTRAOPERATIVE NEUROMONITORING MARKET, BY
END-USERS, 2019-2027 (IN $ MILLION)
TABLE 8: ASIA-PACIFIC INTRAOPERATIVE NEUROMONITORING
MARKET, BY COUNTRY, 2019-2027 (IN $ MILLION)
FIGURE 1: ASIA-PACIFIC INTRAOPERATIVE NEUROMONITORING MARKET, BY APPLICATIONS,
2018 & 2027 (IN %)
FIGURE 2: ASIA-PACIFIC OUTSOURCED INTRAOPERATIVE NEUROMONITORING MARKET,
2019-2027 (IN $ MILLION)
FIGURE 3: ASIA-PACIFIC EP MARKET, 2019-2027 (IN $ MILLION)
FIGURE 4: ASIA-PACIFIC SPINAL SURGERY MARKET, 2019-2027 (IN $ MILLION)
FIGURE 5: ASIA-PACIFIC SERVICES MARKET, 2019-2027 (IN $ MILLION)
FIGURE 6: ASIA-PACIFIC AMBULATORY SURGICAL CENTERS MARKET, 2019-2027 (IN
$ MILLION)
FIGURE 7: PORTER’S FIVE FORCE ANALYSIS
FIGURE 8: MARKET ATTRACTIVENESS INDEX
FIGURE 9: ASIA-PACIFIC INTRAOPERATIVE NEUROMONITORING MARKET, BY
INSOURCED INTRAOPERATIVE NEUROMONITORING, 2019-2027 (IN $ MILLION)
FIGURE 10: ASIA-PACIFIC INTRAOPERATIVE NEUROMONITORING MARKET, BY
OUTSOURCED INTRAOPERATIVE NEUROMONITORING, 2019-2027 (IN $ MILLION)
FIGURE 11: ASIA-PACIFIC INTRAOPERATIVE NEUROMONITORING MARKET, BY EEG
MONITORING, 2019-2027 (IN $ MILLION)
FIGURE 12: ASIA-PACIFIC INTRAOPERATIVE NEUROMONITORING MARKET, BY EMG
MONITORING, 2019-2027 (IN $ MILLION)
FIGURE 13: ASIA-PACIFIC INTRAOPERATIVE NEUROMONITORING MARKET, BY EP
MONITORING, 2019-2027 (IN $ MILLION)
FIGURE 14: ASIA-PACIFIC INTRAOPERATIVE NEUROMONITORING MARKET, BY SEP
MONITORING, 2019-2027 (IN $ MILLION)
FIGURE 15: ASIA-PACIFIC INTRAOPERATIVE NEUROMONITORING MARKET, BY TCMEP MONITORING,
2019-2027 (IN $ MILLION)
FIGURE 16: ASIA-PACIFIC INTRAOPERATIVE NEUROMONITORING MARKET, BY BAEP
MONITORING, 2019-2027 (IN $ MILLION)
FIGURE 17: ASIA-PACIFIC INTRAOPERATIVE NEUROMONITORING MARKET, BY VEP
MONITORING, 2019-2027 (IN $ MILLION)
FIGURE 18: ASIA-PACIFIC INTRAOPERATIVE NEUROMONITORING MARKET, BY SPINAL
SURGERY, 2019-2027 (IN $ MILLION)
FIGURE 19: ASIA-PACIFIC INTRAOPERATIVE NEUROMONITORING MARKET, BY ENT
SURGERY, 2019-2027 (IN $ MILLION)
FIGURE 20: ASIA-PACIFIC INTRAOPERATIVE NEUROMONITORING MARKET, BY
NEUROSURGERY, 2019-2027 (IN $ MILLION)
FIGURE 21: ASIA-PACIFIC INTRAOPERATIVE NEUROMONITORING MARKET, BY
VASCULAR SURGERY, 2019-2027 (IN $ MILLION)
FIGURE 22: ASIA-PACIFIC INTRAOPERATIVE NEUROMONITORING MARKET, BY
ORTHOPEDIC SURGERY, 2019-2027 (IN $ MILLION)
FIGURE 23: ASIA-PACIFIC INTRAOPERATIVE NEUROMONITORING MARKET, BY OTHER
SURGERIES, 2019-2027 (IN $ MILLION)
FIGURE 24: ASIA-PACIFIC INTRAOPERATIVE NEUROMONITORING MARKET, BY
SYSTEMS, 2019-2027 (IN $ MILLION)
FIGURE 25: ASIA-PACIFIC INTRAOPERATIVE NEUROMONITORING MARKET, BY
ACCESSORIES, 2019-2027 (IN $ MILLION)
FIGURE 26: ASIA-PACIFIC INTRAOPERATIVE NEUROMONITORING MARKET, BY
SERVICES, 2019-2027 (IN $ MILLION)
FIGURE 27: ASIA-PACIFIC INTRAOPERATIVE NEUROMONITORING MARKET, BY HOSPITALS,
2019-2027 (IN $ MILLION)
FIGURE 28: ASIA-PACIFIC INTRAOPERATIVE NEUROMONITORING MARKET, BY
AMBULATORY SURGICAL CENTERS (ASCs), 2019-2027 (IN $ MILLION)
FIGURE 29: ASIA-PACIFIC INTRAOPERATIVE NEUROMONITORING MARKET, REGIONAL
OUTLOOK, 2018 & 2027 (IN %)
FIGURE 30: CHINA INTRAOPERATIVE NEUROMONITORING MARKET, 2019-2027 (IN $
MILLION)
FIGURE 31: JAPAN INTRAOPERATIVE NEUROMONITORING MA RKET, 2019-2027 (IN $
MILLION)
FIGURE 32: INDIA INTRAOPERATIVE NEUROMONITORING MARKET, 2019-2027 (IN $
MILLION)
FIGURE 33: SOUTH KOREA INTRAOPERATIVE NEUROMONITORING MARKET, 2019-2027
(IN $ MILLION)
FIGURE 34: ASEAN COUNTRIES INTRAOPERATIVE NEUROMONITORING MARKET,
2019-2027 (IN $ MILLION)
FIGURE 35: AUSTRALIA & NEW ZEALAND INTRAOPERATIVE NEUROMONITORING
MARKET, 2019-2027 (IN $ MILLION)
FIGURE 36: REST OF ASIA-PACIFIC INTRAOPERATIVE NEUROMONITORING MARKET,
2019-2027 (IN $ MILLION)